Study identifies drug target to prevent autonomic dysfunction after spinal cord injury

Credit: Shutterstock Monoclonal antibodies (or mAbs) are a class of therapeutic proteins designed to target specific molecules or cells in the body. They are used

Re­gen­eron is buy­ing Deci­bel Ther­a­peu­tics and its hear­ing loss gene ther­a­pies for a mod­est $109 mil­lion, the com­pa­nies an­nounced Wednes­day morn­ing. Re­gen­eron and Deci­bel have